CASCADE is a research program enrolling patients with advanced metastatic disease who consent to undergo rapid autopsy following death.
Individuals with metastatic disease are consented to CASCADE when they reach the end of life stage, and understand that there are no further curative options available. Tissue donated to CASCADE is used in research aimed at improving outcomes for people with metastatic cancer.
There are several active research projects enabled by CASCADE donors including laboratory based research into breast, ovarian, melanoma, prostate and lung cancer as well as psycho-social research.
For information about the CASCADE rapid autopsy program, please contact [email protected]
CASCADE: BEREAVED EXPERIENCE STUDY
The aim of this study is to explore the experience of bereaved relatives (“carers”) of participants in the CASCADE rapid autopsy program.
The CASCADE: Bereaved Experience study aims to improve our understanding of the overall experience of relatives, and of specific aspects of participation, namely recruitment, period around death and autopsy and bereavement.
The aim of this study is to explore the experience of bereaved relatives (“carers”) of participants in the CASCADE rapid autopsy program. The study aims to improve our understanding of the overall experience of relatives, and of specific aspects of participation, namely recruitment, period around death and autopsy and bereavement.
For information about the CASCADE: Bereaved Experience study, please contact [email protected]
Sponsor
Peter MacCallum Cancer Centre
Funding
Peter MacCallum Cancer Centre, Pain & Palliative Care
